Baidu
map

JCLA:子宫肌瘤雌激素、孕酮受体基因多态性分析

2019-07-15 gladiator MedSci原创

平滑肌瘤是最常见的良性肿瘤之一,在女性生殖年龄发病。然而,目前对该病的分子发病机制尚不清楚。平滑肌瘤是一种激素敏感肿瘤,约20% ~ 25%的女性受其影响。研究基因多态性对于多因素疾病如平滑肌瘤的评估具有重要意义。涉及激素合成和信号化基因的多态性可作为激素相关条件的遗传标记。本研究的目的是分析ERα-351 XbaI A/G, ERα-397 PvuII T/C, 和progesterone re

平滑肌瘤是最常见的良性肿瘤之一,在女性生殖年龄发病。然而,目前对该病的分子发病机制尚不清楚。平滑肌瘤是一种激素敏感肿瘤,约20% ~ 25%的女性受其影响。研究基因多态性对于多因素疾病如平滑肌瘤的评估具有重要意义。涉及激素合成和信号化基因的多态性可作为激素相关条件的遗传标记。本研究的目的是分析ERα-351 XbaI A/G, ERα-397 PvuII T/C, progesterone receptor (PGR) PROGINS对平滑肌瘤发展的影响。

在这项研究中,共纳入213个样本(103名平滑肌瘤患者和110名健康对照组)。使用PCR RFLP方法ERα检测351 XbaI / GERα397 PvuII T / C基因多态性进行了分析。采用特异性引物PCR法分析PGR基因多态性。

ERα的基因型分布及等位基因频率高351 XbaI A / G ERα高397 PvuII T / C, PGR PROGINS多态性在统计学上没有不同平滑肌瘤患者和对照组(p > 0.05)

这项研究表明ERα和PGR PROGINS多态性可能不是平滑肌瘤易感性的遗传因素。

原始出处:

Muhammed Toprak, Omer Ates, Analysis of estrogen and progesterone receptor gene polymorphisms in leiomyoma

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1987130, encodeId=6451198e13039, content=<a href='/topic/show?id=785545324fd' target=_blank style='color:#2F92EE;'>#孕酮受体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45324, encryptionId=785545324fd, topicName=孕酮受体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Sat Dec 28 20:37:00 CST 2019, time=2019-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471051, encodeId=506914e1051f7, content=<a href='/topic/show?id=0b1445323b0' target=_blank style='color:#2F92EE;'>#孕酮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45323, encryptionId=0b1445323b0, topicName=孕酮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fea57099634, createdName=周虎, createdTime=Wed Jul 17 13:37:00 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629287, encodeId=2ea1162928e18, content=<a href='/topic/show?id=0c1c4325170' target=_blank style='color:#2F92EE;'>#多态性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43251, encryptionId=0c1c4325170, topicName=多态性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d83c21331263, createdName=xzw120, createdTime=Wed Jul 17 13:37:00 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369755, encodeId=5bfb369e5597, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Tue Jul 16 09:23:13 CST 2019, time=2019-07-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1987130, encodeId=6451198e13039, content=<a href='/topic/show?id=785545324fd' target=_blank style='color:#2F92EE;'>#孕酮受体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45324, encryptionId=785545324fd, topicName=孕酮受体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Sat Dec 28 20:37:00 CST 2019, time=2019-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471051, encodeId=506914e1051f7, content=<a href='/topic/show?id=0b1445323b0' target=_blank style='color:#2F92EE;'>#孕酮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45323, encryptionId=0b1445323b0, topicName=孕酮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fea57099634, createdName=周虎, createdTime=Wed Jul 17 13:37:00 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629287, encodeId=2ea1162928e18, content=<a href='/topic/show?id=0c1c4325170' target=_blank style='color:#2F92EE;'>#多态性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43251, encryptionId=0c1c4325170, topicName=多态性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d83c21331263, createdName=xzw120, createdTime=Wed Jul 17 13:37:00 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369755, encodeId=5bfb369e5597, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Tue Jul 16 09:23:13 CST 2019, time=2019-07-16, status=1, ipAttribution=)]
    2019-07-17 周虎
  3. [GetPortalCommentsPageByObjectIdResponse(id=1987130, encodeId=6451198e13039, content=<a href='/topic/show?id=785545324fd' target=_blank style='color:#2F92EE;'>#孕酮受体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45324, encryptionId=785545324fd, topicName=孕酮受体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Sat Dec 28 20:37:00 CST 2019, time=2019-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471051, encodeId=506914e1051f7, content=<a href='/topic/show?id=0b1445323b0' target=_blank style='color:#2F92EE;'>#孕酮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45323, encryptionId=0b1445323b0, topicName=孕酮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fea57099634, createdName=周虎, createdTime=Wed Jul 17 13:37:00 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629287, encodeId=2ea1162928e18, content=<a href='/topic/show?id=0c1c4325170' target=_blank style='color:#2F92EE;'>#多态性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43251, encryptionId=0c1c4325170, topicName=多态性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d83c21331263, createdName=xzw120, createdTime=Wed Jul 17 13:37:00 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369755, encodeId=5bfb369e5597, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Tue Jul 16 09:23:13 CST 2019, time=2019-07-16, status=1, ipAttribution=)]
    2019-07-17 xzw120
  4. [GetPortalCommentsPageByObjectIdResponse(id=1987130, encodeId=6451198e13039, content=<a href='/topic/show?id=785545324fd' target=_blank style='color:#2F92EE;'>#孕酮受体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45324, encryptionId=785545324fd, topicName=孕酮受体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Sat Dec 28 20:37:00 CST 2019, time=2019-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471051, encodeId=506914e1051f7, content=<a href='/topic/show?id=0b1445323b0' target=_blank style='color:#2F92EE;'>#孕酮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45323, encryptionId=0b1445323b0, topicName=孕酮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fea57099634, createdName=周虎, createdTime=Wed Jul 17 13:37:00 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629287, encodeId=2ea1162928e18, content=<a href='/topic/show?id=0c1c4325170' target=_blank style='color:#2F92EE;'>#多态性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43251, encryptionId=0c1c4325170, topicName=多态性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d83c21331263, createdName=xzw120, createdTime=Wed Jul 17 13:37:00 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369755, encodeId=5bfb369e5597, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Tue Jul 16 09:23:13 CST 2019, time=2019-07-16, status=1, ipAttribution=)]
    2019-07-16 phoebeyan520

    学习了

    0

相关资讯

Liver Int:孕酮受体的突变使HIV阳性的患者易感戊型肝炎

研究发现,孕酮的一个突变,为免疫抑制个体易感HEV感染,提供了一个研究思路。

J Gastroen Hepatol:孕酮受体、5-羟色胺与缓慢传输型便秘的疾病过程

研究证实孕酮受体与炎症和纤维化一起参与了缓慢传输型便秘的疾病过程

Baidu
map
Baidu
map
Baidu
map